This page brings together nephrology thesis topics and kidney disease research topics suitable for MD/DNB Medicine residents, covering chronic kidney disease, acute kidney injury, haemodialysis, diabetic kidney disease, hypertension-related renal damage, glomerular disease, renal infections, electrolyte and acid-base disorders, obstructive uropathy and systemic kidney involvement. Most designs can be completed within one thesis period using patients, laboratory investigations, dialysis records, urine studies and ultrasonography already available in a teaching hospital. Before registration, the selected question should be converted into a department-specific MD Medicine nephrology protocol and MD Medicine nephrology synopsis.
Last reviewed and updated: September 2026 · 2026–27 admissions
Our MD Medicine Thesis Guidance provides structured protocols, sample size formulas, and institutional review board (IRB) layout guides.
Looking for premium Nephrology thesis topics for your DM? Or the full medicine collection across all sections? Updated September 2026.
📌 Updated for 2026–2027 MD/DNB Medicine Nephrology admissions
The page has been reviewed for practical feasibility, current renal definitions, realistic follow-up windows and investigations commonly available in medical colleges and teaching hospitals.
Select Generate Protocol → beside any title in the list above and receive a submission-ready document built around that topic, containing all eighteen components:
Already have your thesis title?
Generate the full nephrology protocol directly — objectives, methodology, sample size, statistics, timeline, references and annexures.
Generate your protocolAlongside nephrology protocols and synopses, support is also available for departmental presentations, journal club presentations, ethics committee presentations, and posters and oral presentations for medical conferences — for postgraduate residents, board trainees and research scholars across India and the GCC. Prepared by a practising doctor with long experience in medical publishing and thesis supervision.
Enquire on WhatsApp →Nephrology research outside India
The topics above work as research questions anywhere — what changes is the document the institution expects, and who approves it before data collection begins. The Gulf equivalent of an Indian synopsis is the nephrology research proposal submitted to an institutional review board, and it ordinarily carries three sections an Indian synopsis does not: a Gantt chart, a budget and resources section, and a Declaration of Helsinki statement.
Board and residency programmes — country by country
Saudi Arabia — SCFHS and the Saudi Board. Residency and fellowship training under the Saudi Commission for Health Specialties includes a research project with a set timeline, and the nephrology research proposal is the document prepared at the outset and cleared by the institutional review board before recruitment starts.
United Arab Emirates — DHA, DOH Abu Dhabi and MOHAP. Residents training in Dubai, Abu Dhabi and the northern emirates prepare a nephrology research protocol for their programme and submit it for institutional review board approval before any data are collected.
Qatar — DHP (formerly QCHP) and Hamad Medical Corporation. A nephrology IRB proposal is reviewed before recruitment, with the ethics section written to the institution's own template rather than a generic one.
Bahrain — NHRA. Trainees turning nephrology research topics into a project need the proposal cleared by their institutional research and ethics committee before fieldwork begins.
Oman — OMSB. Residency programmes under the Oman Medical Specialty Board include a research component, and the nephrology research proposal is the document assessed at the start of it.
Kuwait — KIMS. A nephrology study protocol goes to the institutional committee for approval before the project begins.
Arab Board programmes across the region. The Arab Board carries its own research requirement irrespective of the host country, and the nephrology proposal follows the same structure throughout.
Postgraduate degrees — Malaysia, the Gulf and beyond
Malaysia — MMed, the National Medical Research Register and MREC. A nephrology dissertation proposal for a Master of Medicine programme carried out in a Ministry of Health facility must be registered on the NMRR and approved by the Medical Research and Ethics Committee before the study begins, and the guidance asks for submission four to six months ahead of data collection. Every investigator on the study team registers on the NMRR as well, so the methodology, ethics and team sections are written in far more detail than an Indian synopsis requires.
PhD and Master's candidates elsewhere. University programmes generally require a full nephrology research proposal of roughly 6,000 to 10,000 words, with an extended literature review, a theoretical framework and a detailed methodology chapter.
PhD and MMed proposals are written individually by a medical doctor and revised until the supervisor accepts them. They are not produced by the automated protocol generator.
Enquire about a nephrology PhD or MMed proposal →🔥 Trending research areas in Nephrology for 2026–27
Define kidney function with the exact equation and laboratory method. The protocol should name the estimated glomerular filtration rate equation, specify the creatinine assay used by the laboratory and state whether values are taken at baseline, admission, peak illness, discharge or follow-up. A change in creatinine method or an undocumented equation can make stage comparisons unreliable.
Fix the time anchor for acute kidney injury. AKI should not be defined simply as "raised creatinine". The protocol must state the baseline creatinine source, the time interval over which creatinine change is assessed, whether urine-output criteria are available and how patients without a known baseline value will be handled.
Distinguish chronicity from a single abnormal result. A low estimated glomerular filtration rate or one elevated urine albumin to creatinine ratio does not by itself establish chronic kidney disease unless chronicity is known from prior records, repeat testing or another accepted marker of chronic kidney damage.
Define the unit of analysis. Dialysis studies may generate many observations from the same patient. The protocol should state whether the unit is the patient, dialysis session, admission or vascular-access episode and should avoid treating repeated sessions as independent observations unless the analysis accounts for clustering.
The synopsis is the concise academic registration document. It generally includes the title, rationale, objectives, design, setting, eligibility criteria, variables, sample size, statistical plan and ethical safeguards required by the institution or university.
The protocol is the operational document. It should additionally define the creatinine assay and estimated glomerular filtration rate equation, AKI baseline definition, albuminuria or proteinuria measurement method, timing of repeat samples, dialysis-session definitions, fluid-status assessment, drug-exposure window and rules for renal recovery.
Nephrology is particularly sensitive to timing. Serum creatinine, sodium, potassium, bicarbonate, urine output and volume status can change within hours after fluids, diuretics, dialysis, decompression or treatment of sepsis. The protocol should therefore state exactly when each variable is measured in relation to treatment.
Base the sample size on the primary objective. Prevalence studies need an expected proportion and precision; correlation studies need an anticipated correlation coefficient; comparative studies need an expected group difference; diagnostic studies require assumptions for sensitivity or specificity; and prospective studies require an expected event rate for outcomes such as dialysis, renal recovery or mortality.
Do not count repeated dialysis sessions or laboratory values as separate independent participants. If each patient contributes several sessions, admissions or time points, use one prespecified observation per participant or a statistical method that recognises repeated measurements.
Match the analysis to the renal variable. Estimated glomerular filtration rate stages, albuminuria categories and AKI stages are ordered categories, while creatinine, urine protein and electrolyte values are continuous variables. Paired pre-treatment and post-treatment values need paired analysis, diagnostic studies need sensitivity and specificity with confidence intervals, and time-dependent outcomes may require survival or repeated-measures methods if follow-up is sufficiently long.
Plan important confounders before recruitment. Age, diabetes, hypertension, sepsis, volume status, chronic liver or heart disease, nephrotoxic medication, baseline kidney function and dialysis exposure can materially affect renal outcomes. Prespecifying a small clinically justified set of confounders is preferable to testing every available laboratory value.
For the 2026–2027 academic year, a feasible topic should use a common renal problem, a routinely available measurement, one clearly defined primary outcome and a follow-up period that fits residency timelines. Before finalising the title, confirm the monthly case load, availability of urine protein or albumin testing, dialysis records, ultrasound access and whether repeat creatinine or follow-up data can be obtained consistently.
Cross-sectional, comparative cross-sectional, case-control, prospective observational, retrospective record-based, diagnostic accuracy, method-comparison, correlation and clinical-audit designs are all suitable when matched to the objective. A study should not be labelled cross-sectional if the primary outcome depends on renal recovery, dialysis requirement, readmission, treatment response or change in creatinine over time.
Settle the exact renal case definition, primary outcome, creatinine baseline, estimated glomerular filtration rate equation, sampling time point, albuminuria or proteinuria method, dialysis or drug-exposure definitions, follow-up duration, confounders and main statistical comparison. If the study depends on a specialised measurement such as ambulatory blood pressure, urine microscopy or dialysis adequacy, confirm that it is routinely available before registration.
Yes, but only if the records contain enough information to reconstruct the AKI definition and outcome. The major limitation is often absence of a reliable pre-admission creatinine or complete urine-output chart. Before registration, review a sample of records to determine how often baseline kidney function, timing of creatinine measurements, dialysis requirement and discharge creatinine are actually documented.
The synopsis is the shorter document used for academic registration, while the protocol contains the detailed operating rules required to conduct the study reproducibly. In nephrology, these rules should include the creatinine assay, estimated glomerular filtration rate equation, AKI baseline, chronicity definition, urine protein measurement, dialysis-session handling, treatment timing and renal-recovery definition.
Prospective studies require informed consent, and paediatric renal studies require guardian consent with age-appropriate child assent from about seven years where applicable. Record-based projects may seek an ethics-approved waiver of consent when risk is minimal and confidentiality is protected. Research should not add contrast, dialysis, kidney biopsy, urinary catheterisation or venepuncture solely to create data; if extra blood sampling is scientifically necessary, the protocol should state an age- and weight-appropriate blood-volume limit. Separate consent is needed for identifiable photographs or video. Severe hyperkalaemia, rapidly rising creatinine, unexpected hydronephrosis, nephrotic-range proteinuria or other clinically important incidental findings should have a named escalation pathway to the treating team or nephrology service.
Baseline kidney function should be prespecified rather than chosen after seeing the admission creatinine. The best source is usually a recent stable pre-illness creatinine from reliable records. If no prior value exists, the protocol should state exactly how such patients will be classified and should avoid silently back-calculating a "normal" baseline because that can misclassify both AKI and underlying chronic kidney disease. Urine-output criteria may strengthen AKI ascertainment when accurately charted, while discharge creatinine or follow-up values can help distinguish incomplete recovery from previously unrecognised chronic disease.
Yes, but the research document and scope should be redesigned rather than simply expanding an MD synopsis. A PhD proposal usually requires a broader conceptual framework, greater originality and more extensive methodology. Gulf training pathways may require a board research project rather than an Indian-style dissertation; this includes programmes linked to SCFHS and the Saudi Board, the Arab Board of Health Specializations, and DHP, DHA, DOH and MOHAP-linked training programmes. The clinical question may remain similar, but approval pathways, sample size, supervision and reporting requirements should be checked against the relevant programme.
Registration should occur after confirming the case load, laboratory access, primary outcome, baseline kidney-function definition, follow-up window and analysis plan, while leaving enough time for ethics approval and recruitment. Topics dependent on uncommon glomerular diseases, kidney biopsy, specialised dialysis measurements or long-term renal outcomes need an especially careful feasibility check before formal submission.
Found a topic that fits your department?
Generate its full protocol — objectives, methodology, sample size, statistics, timeline, references and annexures — in editable format.
Generate your protocol